Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer
基因组复杂性预测激素受体阳性(HR+)/HER2阴性转移性乳腺癌对内分泌治疗和CDK4/6抑制剂的耐药性
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2177
Davis, Andrew A; Luo, Jingqin; Zheng, Tiantian; Dai, Chao; Dong, Xiaoxi; Tan, Lu; Suresh, Rama; Ademuyiwa, Foluso O; Rigden, Caron; Rearden, Timothy P; Clifton, Katherine; Weilbaecher, Katherine; Frith, Ashley; Tandra, Pavan K; Summa, Tracy; Haas, Brittney; Thomas, Shana; Hernandez-Aya, Leonel F; Peterson, Lindsay L; Wang, Xiaohong; Luo, Shujun J; Zhou, Kemin; Du, Pan; Jia, Shidong; King, Bonnie L; Krishnamurthy, Jairam; Ma, Cynthia X
CDK4
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌